ClinConnect ClinConnect Logo
Search / Trial NCT02463162

Trial of Advance Care Planning (ACP) & Goals of Care Designations (GCD) Discussions

Launched by UNIVERSITY OF ALBERTA · Jun 1, 2015

Trial Information

Current as of May 27, 2025

Completed

Keywords

ClinConnect Summary

Background: Respecting patients' preferences for treatment is a key component of high quality end of life care. Alberta Health Services (AHS) has developed tools for public, patient and healthcare provider (HCP) engagement and education (such as guidebooks, videos, and HCP training modules) to support widespread engagement in advance care planning (ACP) and determining Goals of Care Designation (GCD). However, none of these knowledge translation (KT) tools have been validated and they have not been tailored to reflect barriers in the local context.

ACP is defined as a communication process...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * diagnosis of either:
  • 1. heart failure classified as Class III or IV based on New York Heart Association Functional Classification or classified as Stage D based on American Heart Association/American College of Cardiology Heart Failure Classification;
  • 2. renal failure and on dialysis; or
  • 3. metastatic lung, gastrointestinal (including pancreatic) or gynecological cancer and on chemo, radiation therapy or palliative
  • 19 or over
  • able to communicate in English
  • reside within 100 km of Edmonton or Calgary
  • owns a phone
  • Exclusion Criteria:
  • cognitive impairment which would impact ability to give informed consent
  • in crisis
  • first visit or in the case of renal patients, in the first month of dialysis
  • participated in ACP pilot study
  • visual and/or hearing impairment that would impact their ability to see and/or hear the Videos, and/or complete the assessments including the telephone follow-up interviews.

About University Of Alberta

The University of Alberta, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong commitment to scientific excellence and community health, the university facilitates cutting-edge research across various medical disciplines. Its interdisciplinary approach fosters collaboration among researchers, clinicians, and students, ensuring that clinical trials are designed and conducted with the utmost rigor and ethical standards. By leveraging its extensive resources and expertise, the University of Alberta aims to translate research findings into meaningful advancements in patient care and public health.

Locations

Edmonton, Alberta, Canada

Calgary, Alberta, Canada

Edmonton, Alberta, Canada

Calgary, Alberta, Canada

Calgary, Alberta, Canada

Calgary, Alberta, Canada

Calgary, Alberta, Canada

Calgary, Alberta, Canada

Calgary, Alberta, Canada

Calgary, Alberta, Canada

Calgary, Alberta, Canada

Edmonton, Alberta, Canada

Edmonton, Alberta, Canada

Edmonton, Alberta, Canada

Edmonton, Alberta, Canada

Patients applied

0 patients applied

Trial Officials

Konrad Fassbender, PhD

Principal Investigator

University of Alberta

Sara Davison, MD, MHSc (Bioethics)

Principal Investigator

University of Alberta

Jessica Simon, MD

Principal Investigator

University of Calgary

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials